Analogic Executive and Leadership Team

Thomas Ripp, the Chief Executive Officer at Analogic, directs the overarching corporate strategy for medical imaging and security threat detection systems. Ripp manages the alignment of product development with global market demands, ensuring the organization maintains a competitive edge in computed tomography and magnetic resonance imaging sectors. By coordinating with the Board and executive leadership, the Chief Executive Officer drives long-term growth initiatives across North American and international markets. Thomas Ripp prioritizes the integration of advanced digital mammography technology into clinical workflows to improve diagnostic accuracy. This leadership role involves overseeing the transition of complex engineering concepts into scalable commercial products. Through rigorous focus on operational excellence and market expansion, the Chief Executive Officer secures the financial health of the enterprise. Ripp maintains a commitment to innovation, ensuring the company remains a leader in high-stakes security screening and medical diagnostic hardware.

Will Rousmaniere, the Chief Financial Officer at Analogic, manages the fiscal health and capital allocation strategies for the organization. Rousmaniere oversees financial planning, reporting, and risk management to support the development of sophisticated airport security and medical imaging systems. By analyzing market trends in the medical manufacturing sector, the Chief Financial Officer optimizes resource distribution to fuel research and development efforts. Will Rousmaniere collaborates with the executive team to ensure that budgetary constraints align with the strategic goals of the company. This role involves monitoring global economic conditions to mitigate risks associated with international supply chains and manufacturing operations. Through precise financial modeling and cost-control measures, the Chief Financial Officer enhances shareholder value and supports sustainable growth. Rousmaniere maintains strict compliance with regulatory standards, ensuring the financial integrity of the business while facilitating the expansion of threat detection capabilities in global aviation markets.

Christopher Bade, the Chief Operating Officer at Analogic, directs the internal manufacturing processes and supply chain logistics for medical and security hardware. Bade oversees the production of computed tomography and checkpoint screening systems, ensuring high-quality output across all manufacturing facilities. By streamlining operational workflows, the Chief Operating Officer improves efficiency in the assembly of magnetic resonance imaging components. Christopher Bade coordinates with engineering and sales departments to ensure that product delivery timelines meet the requirements of medical practices and airport security clients. This leadership role involves managing the physical infrastructure and production capacity to support global market reach. Through the implementation of lean manufacturing principles, the Chief Operating Officer reduces waste and optimizes the production cycle. Bade maintains a focus on operational scalability, ensuring that the company can rapidly adapt to changing demands in the security and healthcare sectors while maintaining rigorous quality control standards.

Steve Urchuk, the Chief Technology Officer, Imaging & Detection at Analogic, architects the technical roadmap for next-generation medical imaging and threat detection systems. Urchuk leads the research and development teams in creating advanced algorithms for computed tomography and digital mammography. By driving innovation in motion controls and baggage screening technology, the Chief Technology Officer, Imaging & Detection ensures the company remains at the forefront of diagnostic and security hardware. Steve Urchuk collaborates with product managers to translate complex technical requirements into functional, market-ready solutions for global medical and aviation clients. This role involves overseeing the integration of new imaging modalities into existing product lines to enhance performance and reliability. Through continuous technical evaluation and patent development, the Chief Technology Officer, Imaging & Detection secures the intellectual property portfolio of the firm. Urchuk maintains a focus on technological advancement, ensuring that all engineering efforts support the core mission of improving safety and diagnostic precision.